• SPX
  • $5,969.77
  • 0.35 %
  • $21.06
  • DJI
  • $44,224.67
  • 0.81 %
  • $354.31
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,262.08
  • 1.38 %
  • $112.81
  • IXIC
  • $19,013.11
  • 0.21 %
  • $40.69
Accelerate Diagnostics, Inc. (AXDX) Stock Price, News & Analysis

Accelerate Diagnostics, Inc. (AXDX) Stock Price, News & Analysis

Currency in USD Disclaimer

$1.74

$0.07

(4.19%)

Day's range
$1.68
Day's range
$1.77
50-day range
$1.38
Day's range
$2.04
  • Country: US
  • ISIN: US00430H2013
52 wk range
$0.73
Day's range
$5.23


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -33.85
  • Piotroski Score 4.00
  • Grade Hold
  • Symbol (AXDX)
  • Company Accelerate Diagnostics, Inc.
  • Price $1.74
  • Changes Percentage (4.19%)
  • Change $0.07
  • Day Low $1.68
  • Day High $1.77
  • Year High $5.23

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/25/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$3.97
  • Trailing P/E Ratio -0.33
  • Forward P/E Ratio -0.33
  • P/E Growth -0.33
  • Net Income $-61,618,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Accelerate Diagnostics, Inc. Frequently Asked Questions

  • What is the Accelerate Diagnostics, Inc. stock price today?

    Today's price of Accelerate Diagnostics, Inc. is $1.74 — it has increased by +4.19% in the past 24 hours. Watch Accelerate Diagnostics, Inc. stock price performance more closely on the chart.

  • Does Accelerate Diagnostics, Inc. release reports?

    Yes, you can track Accelerate Diagnostics, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Accelerate Diagnostics, Inc. stock forecast?

    Watch the Accelerate Diagnostics, Inc. chart and read a more detailed Accelerate Diagnostics, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Accelerate Diagnostics, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Accelerate Diagnostics, Inc. stock ticker.

  • How to buy Accelerate Diagnostics, Inc. stocks?

    Like other stocks, AXDX shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Accelerate Diagnostics, Inc.'s EBITDA?

    Accelerate Diagnostics, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Accelerate Diagnostics, Inc.’s financial statements.

  • What is the Accelerate Diagnostics, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -5.1097105896, which equates to approximately -510.97%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Accelerate Diagnostics, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Accelerate Diagnostics, Inc.'s financials relevant news, and technical analysis. Accelerate Diagnostics, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Accelerate Diagnostics, Inc. stock currently indicates a “sell” signal. For more insights, review Accelerate Diagnostics, Inc.’s technical analysis.

  • A revenue figure for Accelerate Diagnostics, Inc. for its last quarter?

    Accelerate Diagnostics, Inc. published it's last quarterly revenues at $2.98 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.